• Mashup Score: 9

    Quick Take Video Summary from The New England Journal of Medicine — Tolebrutinib versus Teriflunomide in Multiple Sclerosis

    Tweet Tweets with this article
    • Tolebrutinib is a BTK inhibitor that is being studied for the treatment of relapsing multiple sclerosis. Research findings from the GEMINI 1 and GEMINI 2 trials comparing tolebrutinib with teriflunomide are summarized in a new Quick Take video. https://t.co/kb7KTzJsjO https://t.co/1LbXH48PVm

  • Mashup Score: 11

    Nerandomilast (BI 1015550) is an orally administered preferential inhibitor of phosphodiesterase 4B with antifibrotic and immunomodulatory properties. Nerandomilast has been shown to slow the progr…

    Tweet Tweets with this article
    • Original Article: Nerandomilast in Patients with Progressive Pulmonary Fibrosis (FIBRONEER-ILD phase 3 trial) https://t.co/WLtx356sBv #ATS2025 | @atscommunity https://t.co/Irf3AXfoam

  • Mashup Score: 24

    As-needed use of albuterol–budesonide has been shown to result in a significantly lower risk of severe asthma exacerbation than as-needed use of albuterol alone among patients with moderate-to-seve…

    Tweet Tweets with this article
    • Original Article: As-Needed Albuterol–Budesonide in Mild Asthma (BATURA trial) https://t.co/RaDXohRnGF #ATS2025 | @atscommunity https://t.co/kfkeMGFyN5

  • Mashup Score: 19

    This article from the FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach to such recommendations.

    Tweet Tweets with this article
    • Big news. Common sense, reason, science, and evidence-based medicine finally returning to US public health. @DrMakaryFDA @VPrasadMDMPH @US_FDA An Evidence-Based Approach to Covid-19 Vaccination | New England Journal of Medicine https://t.co/mLScMxUcjC

  • Mashup Score: 18

    EFFECTIVE therapy for most bacterial infections has been developed since the advent of potent antimicrobial agents. Chronic pyelonephritis, however, has been notably refractory to permanent cure. A…

    Tweet Tweets with this article
    • From the NEJM Archive: Treatment of Pyelonephritis — Bacterial, Drug and Host Factors in Success or Failure among 252 Patients (Original Article, May 20, 1965) https://t.co/jssYUB1fdD https://t.co/3JF7XsvnCS

  • Mashup Score: 3

    MULTIPLE myeloma is characterized by an increase of abnormal plasma cells in the bone marrow and monoclonal protein in the serum, often with osteolytic bone lesions. Its course is progressive: anem…

    Tweet Tweets with this article
    • Smoldering multiple myeloma [1980] - @RobertK68033234 & Greipp @NEJM https://t.co/maBa3mbrhS #mmsm 1st use of SMM term

  • Mashup Score: 234

    Nerandomilast (BI 1015550) is an orally administered preferential inhibitor of phosphodiesterase 4B with antifibrotic and immunomodulatory effects. In a phase 2 trial involving patients with idiopa…

    Tweet Tweets with this article
    • Presented at #ATS2025: In the FIBRONEER-IPF phase 3 trial, nerandomilast slowed disease progression in patients with idiopathic pulmonary fibrosis as compared with placebo. Full trial results: https://t.co/gjXxPWFpyR @atscommunity https://t.co/9iLsOtHsiC